Daily Stock List
Mindpix Corp. (MPIX)
PennyStocks24, Jet-Life Penny Stocks, Super Hero Stocks, HEROSTOCKS, and ThePennyBin reported earlier on Mindpix Corp. (MPIX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Mindpix Corp.is a multi-platform media company that lists on the OTC Pink Current Information. The Company focuses on music and multi-media worldwide television program content.Mindpix is a source for the production, distribution and monetization of major music and entertainment events. Mindpix has their headquarters in Las Vegas, Nevada.
The Company owns, develops and licenses intellectual properties and program content across a full rangeof media; Live Events, Television, Internet and Mobile Media. Recently, Mindpix announced that they entered into an agreement with Spectrum Entertainment and ZZYX Entertainment to develop large format 3D films and theaters at iconic China Landmarks.
The objective of this partnership is to place the world's largest screens at the world's most visited attractions, showing films by one of the most experienced large-screen directors, in the world's fastest-growing theater marketand taking them worldwide viaglobal distribution partnerships.
Last month,Mindpix announced that they posted their restated 2011 and 2012 financial statements for the year ended December 31, 2011 and December 31, 2012 and has also posted their financial statements for the six-month period ended June 30, 2013.The year-end statements were restated to reflect the fair value for financial statement purposes of the license for the music catalogue, the settlement of certain obligations of EMax Media and their affiliates by Mindpix, results of operations for their subsidiary that produced the New Beginnings 2012 concert, and stock based compensation.
Earlier this month,Mindpix announced that they entered into an agreement with eMax Media to cancel the license agreement for eMax's music catalogue and for the cancellation of an additional 75 million common shares in addition to the previous cancellation of 325 million common shares that were surrendered for conversion to Series B Preferred Shares. No Series B shares had been issued; however the 325 million common shares had been surrendered and returned to treasury.Mindpix is concentrating on the production and delivery of diverse music and entertainment events.The eMax music catalogue is no longer central to the Company’s business plan.
Mindpix Corp. (MPIX), closed Tuesday’s trading session at $0.0086, down 9.47%, on 6,919,837 volume with 30 trades. The average volume for the last 60 days is 4,546,927 and the stock's 52-week low/high is $0.0008/$0.02.
UC Resources Ltd. (UC.V)
Stockhouse, Agoracom, and AllPennyStocks reported previously on UC Resources Ltd. (UC.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
UC Resources Ltd. is an exploration, development, and production company headquartered in Vancouver, British Columbia. The Company’s principal focus ison production and exploration opportunities in Mexico – in the heart of the Sierra Madre Mining Belt.An emerging producer of Gold and Silver,UC Resources is working on their long term goals to build a mid-tier Production company with a definitefocus on silver and gold development in Mexico. The Company’s shares trade on the TSX Venture Exchange.
UC Resources concentrates on identifying past producing or likely to produce defined acquisition targets that are near term production projects. The Company’s production projects include La Yesca, Xora, La Pinta, and MAR. The current production facility at La Yesca in Mexico is producing revenue which the Company believes will assist them in achieving their goal of the acquisition of near term production targets. UC Resources exploration projects include Xora, MAR, and Copalquin.
In March 2013, the Companyannounced that they successfully concluded physical testing at their La Yesca facility. The results of the testing indicated that tailings already processed at La Yesca can undergo reprocessing by the Company to achieve a reasonable recovery return for silver and gold. The results from the test showed that approximately 75 percent of original recovery could be achieved from the reprocessing of tailings earlierprocessed.
In early June, UC Resourcesannounced that they discovered an additional two major Silver Vein structures within the Xora Concession next to their La Yesca Mill site. The Companyplans to develop Xora to ensure long term mill operations at La Yesca.The Xora deposit is an undeveloped epithermal system of narrow veins that occurs along 700 meters of strike length.
UC Resources’ immediate exploration emphasis for the build-out of the La Yesca project will be the La Colorada mine. This is an important exploration asset situated on the adjacent Xora concession with an inferred mineral resource of 11,730 tonnes grading 0.70 g/t gold and 619 g/t silver.
UC Resources Ltd. (UC.V), closed Tuesday’s trading session at $0.025, even for the day, on 82,000 volume. The stock's 52-week low/high is $0.01/$0.06.
Integral Technologies, Inc. (ITKG)
SmallCapVoice, M2 Communications, FeedBlitz, Bull in Advantage, and OTC Picks reported previously on Integral Technologies, Inc. (ITKG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Based in Bellingham, Washington, Integral Technologies, Inc. isan emerging leader in hybrid conductive plastics. The Companyand wholly owned subsidiary, ElectriPlast Corp., involve in the discovery, development, and commercialization of electrically conductive hybrid plastics used chiefly as raw materials in the production of industrial, commercial, and consumer products and services globally.Integral operates in four segments, which are Aerospace & Defense, Transportation, Industrial Materials, and Electronics. Theirprimaryproduct line is ElectriPlast™ with Flexible Content Technology™. Integral Technologies’ shares trade on the OTC Markets’ OTCQB.
ElectriPlast™ with Flexible Content Technology™ is a family of non-corrosive, electrically-conductive resin-based materials. Its properties allow it to be molded into any of the countlessshapes and sizes associated with plastics, rubbers and other polymers while reducing component weight by 40 percent to 60 percent. Applications for ElectriPlast® include Shielding Wire, Power Electronics, Connectors, and Cables; Shielding , Conduction, Batteries, Semiconductors, Heated Elements, Sensors, Antennas, Medical Devices, Consumer Electronics and Acoustics, Fuses, Capacitors, Resistors, RFID, Busbars and Terminals.
Yesterday,Integral Technologiesannounced that they will host international high-tech materials maker Hanwha L&Cat Jasper Rubber Products, Inc., the U.S. manufacturer of Integral's proprietary ElectriPlast® product line. The Hanwha visit will occur later this month. It will allow for the exchange of Integral's proprietary processes involved in the science and manufacture of ElectriPlast, marking a milestone toward the further execution of a major licensing and distribution agreement announced between the parties earlier in 2013.
Integral Technologies and Hanwha L&C recently signed a 10-year agreement. This agreement grants Hanwha L&C an exclusive right to sell, distribute, and manufacture ElectriPlast in South Korea. Furthermore, Hanwha has acquired non-exclusive sales and distribution rights to ElectriPlast in Japan, Taiwan, and China. Hanwha L&C is part of the Hanwha Group of companies that together form one of the largest conglomerates in South Korea.
Integral Technologies, Inc. (ITKG), closed Tuesday’s session at $0.4672, up 8.65%, on 592,254 volume with 236 trades. The average volume for the last 60 days is 115,950 and the stock's 52-week low/high is $0.17/$0.83.
San West, Inc. (SNWT)
PennyStocks24 reported earlier on San West, Inc. (SNWT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
San West, Inc.is a growing leader in the power and motor sports based, administrative and fulfillment industry. The Company involves in the retail sales of Scooters, ATV's, and UTV's online and at their retail location. San West's retail store location in Southern California specializes in the sales of on road scooters. The Company is based in California and their shares list on the OTC Pink Current Information.
San West is the home for all facets of the individual motor sport and Off Road Vehicle (ORV) industry. This includes off-road buggies, ATV’s, dirt bikes; scooters, motorcycles, e-bikes; and parts. The Company’s primary service outlet in California provides customers with modification parts, accessories, and repair services for off-road buggies built in China for the U.S. market.
This month,San West announced the launch of a new growth initiative designed to increase shareholder value by way of improved transparency and the roll-out of a revitalized business strategy.The Company is working to establish their e-commerce platform, Joy Ride Motors (www.JoyRideMotors.com), as their flagship brand and chief revenue stream.
The Joy Ride website featuresan extensive selection of more than 300, high quality on-road vehicles. These include scooters, mopeds, motorcycles, trikes, electric bikes, and E-cars. The Joy Rides lifestyle platform also displays a complete line of competitively priced, high performance power-sport vehicles. These include ATV’s, UTV’s, Side-by-Sides, Dune Buggies, Go-Karts, and Dirt& Pit Bikes.
Furthermore, Joy Ridesperforms as an evolving lifestyle brand. Joy Rides promotes responsibility and encourages motor and power sports enthusiasts to do it right throughtheir own website and an active social media presence. An online dealership,Joy Ride Motors does not directly import, neither do they manufacture, any of the gas powered vehicles sold on theirwebsite.
Joy Rides selectively sources on and off road product from the combined inventories of BMS, Roketa, Ice Bear, Kandi, SSR, Sky Team, Excalibur, Road Rat, Snyder and Sunny Motorsports. In addition, the Company offers select products from Sachs, Genuine Scooters aka Buddy 125cc, Piaggiao, Vespa, Lambretta, Kawasaki, Honda, Suzuki and Yamaha in their original equipment manufacturer(OEM) versions.
San West, Inc. (SNWT), closed Tuesday at $0.0025, down 28.57%, on 440,000 volume with 4 trades. The average volume for the last 60 days is 3,154,367 and the stock's 52-week low/high is $0.0004/$0.0086.
Universal Bioenergy, Inc. (UBRG)
Pastwellness.com, Stock Analyzer, Investor News Source, and Stock Alerts reported previously on Universal Bioenergy, Inc. (UBRG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Universal Bioenergy, Inc.is an independent diversified energy company whose shares trade on the OTC Markets’ OTCQB. The Companyproduces and markets natural gas, electricity, petroleum, coal and propane. In addition, Universal Bioenergy engages in the acquisition and development of existing or recently discovered oil and gas fields, leases and surface coal mines. Incorporated in 2004, the Company has their headquarters in Irvine, California.
The Company’s chief business focus is the production, marketing and sales of natural gas, oil and alternative energy. Through their 49 percent owned subsidiary, NDR Energy Group, LLC, they currently sell natural gas to 29 of the largest public utilities, electric power producers, and local gas distribution companies. Universal Bioenergy’sstrategy and business plan is to be one of the top vertically integrated independent energy companies in the U.S.
On February 28, 2012, Universal Bioenergy announced that they closed the transaction for the acquisition of a 40 percent stake in the Whitesburg Friday Branch Mine, LLC, a producer and provider of thermal steam coal in eastern Kentucky.With this acquisition, the Company expanded into the coal energy market sector.
Yesterday,Universal Bioenergy announced that their subsidiary, NDR Energy Group, was awarded another contract to supply natural gas to one of the largest natural gas distribution companies in the U.S. The customer provides natural gas to over 2.2 million customers in a service territory that covers a large portion of the upper Midwest. The expectation is that the contract will generate considerable revenues for the Company.
NDR Energy Group's President, Mr. Ken Harris said, "We are very pleased with this transaction. We are seeing a very favorable upward trending at NDR. This is one of the earliest gas transactions that we have ever completed during a month. And, this sale is to a treasured customer that with whom we have a renewed relationship. We continue to grow our volumes of gas sales to the mid-western states. Additionally, we are pushing towards consistent sales in almost every geographic region in the United States. Over the next few weeks, we will be working diligently to finalize additional substantial gas transactions for September. This transaction is a great start concerning that goal."
Universal Bioenergy, Inc. (UBRG), closed Tuesday’s trading session at $0.002, up 11.11%, on 7,121,785 volume with 54 trades. The average volume for the last 60 days is 9,020,021 and the stock's 52-week low/high is $0.0011/$0.012.
U.S. Energy Initiatives Corp., Inc. (USEI)
OTCEquity, Top Best Pennystocks, VIP Penny Stocks, and Simply Best Penny Stocks reported today on U.S. Energy Initiatives Corp., Inc. (USEI), Investor News Source, The Stock Psycho did earlier, and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
U.S. Energy Initiatives Corp., Inc.is a diverse energy firm with corporate headquarters inSanta Clarita, California. The Company has three separate energy initiatives; one in the oil, gas & technology sector, one in the hybrid fuel or bio-fuel sector, and one in the automotive sector. Management's new goal is to develop their new and old technologies and to build an active energy firm. Established in 1996, U.S. Energy Initiatives lists on the OTC Pink Current Information.
The Company has a long history of developing automotive and hybrid fuel systems and technologies. Their immediate goal is to develop their bio-fuel opportunities. Moving ahead, their goal is to acquire and develop stranded or un-recovered oil properties for enhanced oil production, create partnerships with operators, and create strategic alliances for primary and secondary recovery.
For this year, U.S. Energy Initiatives is concentrating on bio-fuel first, then later the Company’s oil and gas technologies. The Company has establishedjoint ventures (JVs) with two companies that have substantialsuccess in this field. Prometheus is a producing bio-fuel company located in Temecula, California; Methes Energies is a Canadian bio-fuel equipment producer. Under U.S. Energy Initiatives’JVs with these companiesthey will develop a bio-diesel producing plant in Southern California with a capacity of producing over 1 million gallons per year.
In June,U.S. Energy Initiatives announced that the Company and Promethean Biofuels signed a biodiesel production agreement. The companies will work together to bring this facility to its maximum capacity. Promethean has the capacity to produce 2.1 to 3 million gallons of biodiesel per year (MGY) if producing at these levels. This is a 12 month agreement and the Parties agreed to divide the revenue produced by the sale of fuel produced (less cost). This should be greater than $6 million dollars per annum.
Today,U.S. Energy Initiatives announced that the Company has startedproducing biodiesel via their joint venture partner relationship. The design of this partnership is to help meet California’s Mandated Requirement for biodiesel under the Low Carbon Fuel Standard (LCFS). In the next few months the Company indicates that they will build towards the name plate capacity and generate considerablecapital. This venture is part of acontinuingand carefully coordinated plan that both firms have planned throughout 2014.
U.S. Energy Initiatives Corp., Inc. (USEI), closed today at $0.0015, up 7.14%, on 64,762,508 volume with 370 trades. The average volume for the last 60 days is 5,161,120 and the stock's 52-week low/high is $0.001/$0.025.
TechPrecision Corp. (TPCSE)
Today we are reporting on TechPrecision Corp. (TPCSE), at the QualityStocks Daily Newsletter.
TechPrecision Corp., by way of their wholly owned subsidiaries, Ranor, Inc., and Wuxi Critical Mechanical Components Co., Ltd., manufactures large-scale, metal fabricated and machined precision components and equipment worldwide. The Company’s aim is to be an end-to-end global service provider to their customers by furnishing customized and integrated "turn-key" solutions for completed products requiring custom fabrication and machining, assembly, inspection and testing.
TechPrecision’s shares trade on the OTC Bulletin Board. Founded in February 2006, the Company is based in Center Valley, Pennsylvania.TechPrecision’s products are used in an array of markets. These include alternative energy (Solar and Wind), medical, nuclear, defense, industrial, and aerospace, among others.
Founded in 1956, the Company’s Ranor subsidiary specializes in large-scale, precision component fabrication for the Cleantech, energy, medical, aerospace, and defense sectors. Ranor’s capabilities encompassProduction Control Engineering; Processing; Fabrication; Machining; Assembly & Finishing; NDE & Inspection, and Quality Assurance.
TechPrecision’sWuxi Critical Mechanical Components (CMC)subsidiary (founded in 2010) is designed to meet the increasing worldwide demand for an experienced, knowledgeable machining and distribution center in Asia, providing large-scale component fabrication solutions for the region's solar and wind power challenges. CMC employs one of the largest forges in the industry. CMC’s capabilities includeForging; Fabrication; Machining; Inspection; Assembly & Finishing, and Quality Assurance
Today,TechPrecision reported financial results for the fourth quarter and full-year periods of fiscal year 2013, the periods ended March 31, 2013. Pertaining to theFourth Fiscal Quarter 2013, net sales increased 64 percent to $9.9 million, in comparison to $6.1 million in the prior year quarter. Gross profit was $1.6 million, or 16 percent gross profit margin. This is in comparison to gross profit of $1,883, or 0.03 percent gross profit margin, in the prior year quarter. The net loss was $(1.1) million for the fourth quarter, in comparison to a net loss of ($1.3) million in the year ago fourth quarter.
TechPrecision Corp. (TPCSE), closed Tuesday’s trading session at $0.58, even for the day, on 189,650 volume with 74 trades. The average volume for the last 60 days is 15,972 and the stock's 52-week low/high is $0.355/$1.42.
Foodfest International 2000, Inc. (FDFT)
PennyStocks24, Wallstreetlivechat, TheStockWizards.net, PennyStockCrowd, Blaque Capital Stocks, Club Penny Stocks Network, and Penny Stocks Profile reported this month on Foodfest International 2000, Inc. (FDFT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Foodfest International 2000, Inc. (FDFT)recently acquired Restore Force, Inc. FDFT's board of directors determined the business opportunity represented by Restore Force to be superior to their previous business.FDFT has adopted the business plan of Restore Force.The Company, via their wholly-owned subsidiary, Restore Force, serves Palm Beach, Martin, and Saint Lucie counties in Florida, with their damage restoration services. This includes water damage restoration, mold remediation and fire damage restoration. FDFT is based in Jupiter, Florida. The Company’s shares trade on the OTC Pink Current Information.
The Company’s Restore Force subsidiary also provides re-construction services following their initial restoration efforts. During the past three years, Restore Force has experienced an almost 500 percent growth in revenues. Restore Force expects additional revenue growth for all of 2013.
Restore Force handles any size job, from large to small, and from commercial to residential to industrial. This subsidiary hasIICRC certified technicians, certified general contractors, crew, and equipment. Restore Forceis available to respond 24 hours a day, 7 days a week, 365 days a year, and in some situations, they will travel anywhere in the nation.
Pertaining to water damage restoration, Restore Forceservices include comprehensive damage assessment; full water extraction and removal of excess moisture; complete indoor air quality and humidity control; disinfection & anti-microbial treatments; sanitation & deodorization, and direct insurance billing.
Emergency services includewater extraction; structural drying; desiccant dehumidification; board-ups; selective & full demolition; electronics recovery; document drying, and generator & drying equipment. Restoration services includecomplete project management; project estimating; interior/exterior renovations; structural engineers; contents cleaning & storage; carpet/tile cleaning, and ozone treatment.
Yesterday,Foodfest International 2000 (FDFT), reported that their Restore Force continues to experience overall business expansion and revenue growth. In addition, FDFT announced that, starting in Q4 2013, they would turn their attention to finalizing their growth-through-acquisition strategy.
Foodfest International 2000, Inc. (FDFT), closed at $0.01, up 11.11%, on 1,645,536 volume with 29 trades. The average volume for the last 60 days is 177,348 and the stock's 52-week low/high is $0.005/$0.09.
On the Move Systems, Inc. (OMVS)
The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $0.148, up 48.00%, on 608,945 volume with 113 trades. The stock’s average daily volume over the past 60 days is 39,641, and its 52-week low/high is $0.0027/$0.185.
On The Move Systems Corp. reported today that, after formally announcing its revolutionary new business model to capture a share of the booming $300 billion online transportation sector, the company is wasting no time in lining up emerging transportation providers for potential partnership and acquisition. On The Move Systems has already initiated talks with private air carriers, ground transportation services and intermodal and logistics providers well-positioned to help the company achieve its mission to create a next-generation online transportation portal that can compete with the likes of Expedia, Travelocity, and Orbitz.
On the Move Systems, Inc. (OMVS) has established a scalable business model for leveraging the available routes and “legs” of private aviation to book private air charter, freight, and animal/exotic transport services. Their unique ISTx software is designed for managing and supporting services and routes across multiple private/commercial carriers through this single platform.
Management places strong emphasis on customer satisfaction and approaches this viewpoint by creating a unique flight or service profile for each client. The company has developed a business model offering this profile access through various proprietary and membership models. Additionally, its business strategy incorporates acquiring or joining with smaller charter plane owners. The company has further established various divisions which address particular client needs and routes. Leveraging its unique business model with a host of innovative solutions for expanding markets, OMVS is well positioned for rapid growth.
Current divisions of OMVS include Charter Services, Inter-Modal Freight, and Animal/Exotic Transport. The Charter Services Division offers private charter airplane owners the opportunity to enter a network where available planes will be "on-call" to deliver private air charter service on demand. The Inter-Modal Freight Division provides charter and freight shipping services to clients who need to expedite shipment of cargo and freight globally – including medical transport for tissue and isotopes. The company's Animal/Exotic Transport Division affords clients the security of transporting pets and animals without the accompaniment of the owner.
OMVS continues to develop technology and applications that connect all business touch points - passengers, assets, and routes. The company intends to monitor daily operations through a single platform providing ultimate support for all business activities. OMVS is in the final stages of development with the ISTx platform and plans to implement system wide in the next two fiscal quarters.
On the Move Systems, Inc. Company Blog
On the Move Systems, Inc. News:
OMVS Lines Up New Acquisition Targets in $300 Billion Online Transportation Industry
OMVS Officially Relaunches with New Transportation Business Model
OMVS Adds Ground Options to Luxury Transportation Portal
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $2.95%, even with yesterday's close, on 18,108 volume with 43 trades. The stock’s average daily volume over the past 60 days is 1,572, and its 52-week low/high is $2.90/$19.375.
Advaxis Inc. announced the appointment of Daniel J. O’Connor, formerly the company's Executive Vice President, to the position of President and Chief Executive Officer today, with Mr. O’Connor also taking a seat on the company's Board. O’Connor brings fifteen years of executive experience in the biopharmaceutical industry with ImClone Systems and Bracco Diagnostics to the table, having served as ImClone’s Senior Vice President, where he played a key role in resolving numerous issues facing ImClone and closed several important deals leading to its sale to sector juggernaut, Eli Lilly, in 2008.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis Appoints Daniel J. O’Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board
Advaxis’ ADXS-HPV Granted Orphan Drug Designation for Treatment of HPV-Associated Anal Cancer
Advaxis Updates Business Outlook for 2013
OxySure Systems, Inc. (OXYS)
The QualityStocks Daily Newsletter would like to spotlight OxySure® Systems, Inc. (OXYS). Today, OxySure Systems, Inc. closed trading at $0.80, off by 4.74%, on 18,280 volume with 13 trades. The stock’s average daily volume over the past 60 days is 6,488, and its 52-week low/high is $0.35/$2.75 .
OxySure Systems, Inc. reported being featured today in a new audio interview by Small Cap Stock Newsletter service, QualityStocks, the full audio of which can be heard at http://dtg.fm/OXYS-Interview-08-20. In the interview, Julian Ross, Chairman and CEO of OXYS, expounds on the company's patented respiratory and medical technology, its current applications, as well as future plans for widespread installation of their medically pure oxygen generators that use inert powders, both here in the U.S. and abroad.
OxySure Systems, Inc. (OXYS) is a medical technology company focused on developing, manufacturing, and distributing specialty respiratory and medical solutions. The company has developed a unique platform technology that instantly creates medically pure oxygen from two dry, inert powders, allowing oxygen to be delivered on demand. This cutting-edge technology has already been granted FDA-approved for commercial sale.
The company is targeting multiple enormous end markets with no direct competition. OxySure initially plans to focus on the 102,265 educational campuses, 350,735 manufacturing facilities, 350,000 churches, 12 million recreational vehicles (RVs), 8 million boats and yachts, 950,000 restaurants, and hundreds of thousands of other commercial and municipality facilities in the U.S. Outside the US, OxySure has also already signed significant distribution agreements, including Australia, New Zeeland, the United Kingdom, the Netherlands, Luxembourg, Belgium, Brazil, and South Africa. OxySure’s potential market is at least as large as AEDs and potentially as large as fire extinguishers, which together total at least 500+ million units worldwide.
OxySure’s flagship product, OxySure Model 615, introduces the first new oxygen technology in 50 years. There are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training, and the technology is both safe and easy-to-use for the layperson. It can be placed virtually anywhere to help save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.
The company aims to capitalize on market opportunities primarily through partnerships with distributors and OEM customers. Protected by numerous issued patents and patents pending, the company’s products are available over-the-counter without the need for a prescription and has already saved thousands of lives around the globe during various types of medical emergencies. Disclaimer
OxySure Systems, Inc. Company Blog
OxySure Systems, Inc. News:
OxySure Systems, Inc. CEO Featured in Exclusive QualityStocks Interview
OxySure Systems Reports Second Quarter 2013 Results
OxySure Systems to Host Second Quarter 2013 Financial Results Conference Call at 9:00 am ET on August 13, 2013
Rafarma Pharmaceuticals, Inc. (RAFA)
The QualityStocks Daily Newsletter would like to spotlight Rafarma Pharmaceuticals, Inc. (RAFA). Today, Rafarma Pharmaceuticals, Inc. closed trading at $0.65, up 30.00%, on 8,665 volume with 6 trades. The stock’s average daily volume over the past 60 days is 54,318, and its 52-week low/high is $0.041/$0.98.
Rafarma Pharmaceuticals, Inc. (RAFA) is a multiproduct pharmaceutical company specializing in the production of generic antibiotics and specialty pharmaceuticals, including its own proprietary products approved by the ministry of health. Rafarma stands as one of the most ambitious projects in recent medical history, having constructed the most technologically advanced pharmaceutical plant in Russia.
Based in Terbuny, Lipetsk region, Russia, Rafarma possesses a unique niche in the burgeoning pharmaceutical market and is poised to become a major player in the international drug industry. The company was established under the auspices of the Foundation to Support Health Care and has been approved by the Ministry of Health.
Rafarma recently received the general license for pharmaceutical products and began manufacturing three new products: Sodium Para-Aminosalicilate, Ibuprofen, and Betagistin. Receiving the general license was one of the final steps the company needed to open its new plant in Terbuniv, and Rafarma has been named one of only four national strategic pharmaceutical suppliers to the Russian Federation.
Advances in health care science, medicine, and technology have increased the general life expectancy of Eastern European citizens steadily over the past decade. Elderly citizens, which comprise the largest portion of the pharmaceuticals market, have bolstered demand for pharmaceuticals nationwide. Rafarma is well positioned to capitalize on the expanding industry with its strong relationships and state-of-the-art production facility. Disclaimer
Rafarma Pharmaceuticals, Inc. Company Blog
Rafarma Pharmaceuticals, Inc. News:
Rafarma Pharmaceuticals, New Dialysis Research and Development Center to Join Rafarma in Making Terbuny Russia's New Biotech Hub
Rafarma Announces Cooperative Effort With Christian Albrecht University in Kiel, Germany
Rafarma Pharmaceuticals Operational Subsidiary Introduces New Board of Directors
On the Move Systems is advancing quickly. Yesterday the company announced its revolutionary business model designed to foster rapid growth in the booming $300 billion online transportation sector. Today On the Move Systems reports that it is wasting no time lining up emerging transportation providers for potential partnership and acquisition.
According to a press release issued this morning, On the Move Systems has already initiated talks with private air carriers, ground transportation services, and intermodal and logistics providers well-positioned to help the company achieve its mission to create a next-generation online transportation portal. Kayak, Expedia, Travelocity, and Orbitz have clearly revolutionized the way we travel, and OMVS is currently exploring new opportunities to raise a similar revolution for people and businesses looking to avoid the big airlines and shipping companies without paying exorbitant fees.
“The online transportation segment has been forecast by many experts to represent almost a third of the trillion-dollar global transportation market,” stated OMVS CEO Patrick Brown. “The evolution of this industry is far from over, and we believe we have the technology to push this sector into a new era of customer service.”
By offering easy, round-the-clock access to niche service providers, OMVS plans to market new technology solutions that will allow it to compete in the online transportation market alongside Priceline.com (PCLN), TripAdvisor.com (TRIP) and Expedia.com (EXPE).
For more information, visit www.onthemovesystems.com
Advaxis, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the appointment of Daniel J. O’Connor, formerly Executive Vice President, to the position of President and Chief Executive Officer. Mr. O’Connor has also joined the Board of Directors. Dr. James Patton, currently the Chairman of the Audit Committee, has been elected Non-Executive Chairman of the Board. The former Chairman and CEO, Thomas A. Moore, will continue to serve on the Board of Directors and as a consultant to the company.
Mr. O’Connor has fifteen years of executive experience in the biopharmaceutical industry with ImClone Systems, formerly (NASDAQ: IMCL), PharmaNet (now inVentiv Health Clinical), and Bracco Diagnostics. As ImClone’s Senior Vice President, he played a key role in resolving numerous issues facing ImClone and closed several important deals leading to its sale to Eli Lilly (NYSE: LLY) in 2008.
Dr. Patton is a founding member of the Advaxis Board of Directors, an internist, and the Vice President of Millennium Oncology Management, Inc., which provides management services in oncology. Dr. Patton is also an Independent Trustee for the DundeeWealth U.S. mutual fund family and a founder and chairman of VAL Health, LLC, a healthcare consulting company.
“We sincerely thank Tom Moore for his tireless efforts leading Advaxis for the last 6+ years,” stated Dr. Patton. “Importantly, the ADXS-HPV proprietary technology platform has achieved proof of concept and Tom has assembled an experienced management team to continue to advance the clinical pipeline. Over the past six months, the Advaxis team has accelerated its licensing negotiations, achieved several clinical milestones including the recent designation of orphan drug status for ADXS-HPV in anal cancer, and has worked to improve its balance sheet; all of which have been fundamental advancements of the Company’s business. However, we know there still is a lot to accomplish to take Advaxis to the next platform and we remain focused on the goal of unlocking significant stockholder value.”
“The Company is now entering a transformational phase, and Dan’s appointment as CEO is the outcome of Tom and the Board’s succession planning initiatives over the past year in preparation for this important time. Dan has brought tremendous energy to Advaxis since joining in January, and we believe his industry experience and professional track record are perfectly aligned with the Company’s strategic priorities,” concluded Dr. Patton.
Mr. O’Connor stated, “I am very pleased to be appointed to lead Advaxis at this pivotal point in its drug development and commercialization efforts, and I am prepared for this challenge. The Company’s innovative science and IP hold great promise for addressing many important areas of unmet medical needs. We have an excellent team in place, and together we will be focused on continuing to fundamentally transform the Company on multiple fronts, including the preparation for our registration studies with ADXS-HPV and continuing to strengthen our balance sheet. I would like to thank the Board of Directors and Tom for their vote of confidence in me, the Advaxis team for their commitment to the success of the Company, and our stockholders for their continued support over the past several months and in the years ahead.”
Thomas A. Moore added, “I am grateful for having had the opportunity to lead Advaxis and wholeheartedly believe this is the right time for Dan to transition to CEO of the Company. I will work in every way to support Dan, the Board, and the team in their expected coming accomplishments and am pleased to work with the Company as a consultant during this time. I will continue to be a significant stockholder and Director of Advaxis, and will support the Company as needed in the future.”
For more information, visit www.Advaxis.com
Today before the opening bell, QualityStocks announced that a new audio interview with OxySure Systems, Inc. is available. The interview can be heard at http://dtg.fm/OXYS-Interview-08-20.
OXYS is a medical technology company that has pioneered a solution to produce medically pure oxygen from inert powders. The company’s flagship product, the OxySure Model 615, is both safe and easy-to-use for the layperson. Like an AED or fire extinguisher, Model 615 can be placed just about anywhere a medical emergency might occur to help improve medical outcomes and save lives by providing potentially life-saving oxygen in a medical emergency before the arrival of first responders.
In the interview, Julian Ross, Chairman, CEO of OXYS, detailed the company’s patented technology, its current applications, as well as future plans for widespread installation both in the U.S. and abroad.
“We’ve been able to accomplish a lot in 2013 so far, and we’re just halfway,” says Ross, describing the company’s achievements this year, including new domestic installations of Model 615 and recent worldwide contracts.
Ross also highlights second-quarter financial results, in which the company posted significantly higher sales and a narrowed quarterly loss. The company grew second-quarter sales by approximately 657% to $476,071, marking the company’s second consecutive quarter of triple-digit revenue growth.
“We’ve been excited about our results for the second quarter. We have focused — and this has been a big goal for us — to grow the top line. We’ve been able to do that and we’ve set a trend,” says Ross.
For more information, visit www.OXYS.QualityStocks.net
It’s no news that China’s explosive entry onto the world economic stage has been historic. Since serious economic reforms began in China back in the late 1970s, gradually introducing and supporting market-oriented policies and private ownership, China has become the fastest growing major economy in the world. The mix of even marginal capitalism with over 1.3 billion people was unprecedented, and soon caused economic waves around the world as the business potential represented by this revolution began to be recognized.
Today China is already the world’s second biggest economy, and stands to surpass the U.S. in a number of measures. It has been a high-speed economic transition like no other in history, offering investment opportunities for businesses and individuals like never before.
But investment in China was soon recognized to carry risks. An economy as large as China’s, and still growing rapidly, can lead to unexpected turbulence as new money crashes against old institutions and older traditions. Growth and change on such a scale would be problematic in any environment, but China, with its bureaucratic political system and still developing economic infrastructure, poses special challenges. China is, after all, not the West.
All of this represents opportunity for Dragon Capital Group, a company that has learned how to serve as an effective conduit between fast-growing Chinese companies and Western investors. To developing Chinese companies, Dragon provides support in the critical functions of general business consulting, formation of joint ventures, access to capital, merger & acquisition, business valuation, and revenue growth strategies. To investors, Dragon represents a more secure and promising access to what some are calling the Chinese economic miracle.
Dragon operates through 6 subsidiaries in China, with a special focus on the technology market, including the development of wireless applications and business solutions. Two companies that Dragon has already acquired are among the leading providers of mobile applications and business software in China. In short, Dragon aims to emerge as a significant force in the high-tech sector of China.
For additional information, visit www.DragonCapital.us
Today's Top 3
FOX Penny Stocks
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Appoints Daniel J. O’Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board
- All Grade Mining, Inc. (HYII) Takes Initial Steps to Acquire Second Mining Project in Chile
- Calpian, Inc. (CLPI) Money-on-Mobile Grows to Serve over 57 Million Unique Users
- Consorteum Holdings, Inc. (CSRH) Forms a New, Wholly Owned Subsidiary
- DoMark International, Inc. (DOMK) Acquires Unique Wireless Portable Plug and Print Patent Pending Printer for Smartphone/Digital Cameras.
- Dragon Capital Group Corp. (DRGV) Subsidiary Awarded Contract for Central Control System Upgrade at Huinan Waterworks Facilities
- Epazz Inc. (EPAZ) Client Base Grows Over 500% in 3 Years
- GlobalWise Investments, Inc. (GWIV) Announces Software Collaboration With Primary Solutions
- GNCC Capital, Inc. (GNCP) Potential Low Cost Mining at Gold Hills Property
- Intelimax Media, Inc. (IXMD) Corporate Update
- International Stem Cell Corp. (ISCO) Announces Second Quarter 2013 Financial Results
- Mabwe Minerals Inc. (MBMI) Completes Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.
- Max Sound Corp. (MAXD) Announces New Music Website, Adds Over 7.5 Million Songs and Experiences Record HD Audio Mobile App Demand
- NanoTech Entertainment, Inc. (NTEK) Reports Record Quarterly and Annual Revenue
- On The Move Systems Corp. (OMVS) Lines Up New Acquisition Targets in $300 Billion Online Transportation Industry
- OxySure Systems, Inc. (OXYS) CEO Featured in Exclusive QualityStocks Interview
- Rafarma Pharmaceuticals, Inc. (RAFA) New Dialysis Research and Development Center to Join Rafarma in Making Terbuny Russia's New Biotech Hub
- Raptor Resources Holdings Inc. (RRHI) Mabwe Minerals Commences Mining Operations at Dodge Mine
- Solar Wind Energy Tower, Inc. (SWET) Wall Street Transcript Interview with Ronald W. Pickett, the President, CEO and Chairman of Solar Wind Energy Tower, Inc.
- StreamTrack, Inc. (STTK) RadioLoyalty Signs TargetSpot
- VistaGen Therapeutics, Inc. (VSTA) Provides Update on $36 Million Strategic Financing Agreement